GR3031293T3 - Tylosin containing sustained release veterinary compositions - Google Patents
Tylosin containing sustained release veterinary compositionsInfo
- Publication number
- GR3031293T3 GR3031293T3 GR990402391T GR990402391T GR3031293T3 GR 3031293 T3 GR3031293 T3 GR 3031293T3 GR 990402391 T GR990402391 T GR 990402391T GR 990402391 T GR990402391 T GR 990402391T GR 3031293 T3 GR3031293 T3 GR 3031293T3
- Authority
- GR
- Greece
- Prior art keywords
- sustained release
- tylosin
- release veterinary
- veterinary compositions
- containing sustained
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939306106A GB9306106D0 (en) | 1993-03-24 | 1993-03-24 | Sustained release veterinary composition |
| PCT/GB1994/000578 WO1994021267A1 (en) | 1993-03-24 | 1994-03-22 | Tylosin containing sustained release veterinary compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3031293T3 true GR3031293T3 (en) | 1999-12-31 |
Family
ID=10732660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR990402391T GR3031293T3 (en) | 1993-03-24 | 1999-09-22 | Tylosin containing sustained release veterinary compositions |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0689444B1 (el) |
| JP (1) | JPH08508032A (el) |
| KR (1) | KR100283369B1 (el) |
| CN (1) | CN1096268C (el) |
| AT (1) | ATE181834T1 (el) |
| AU (1) | AU669435B2 (el) |
| BG (1) | BG62352B1 (el) |
| BR (1) | BR9406202A (el) |
| CA (1) | CA2158662C (el) |
| DE (1) | DE69419408T2 (el) |
| DK (1) | DK0689444T3 (el) |
| ES (1) | ES2135568T3 (el) |
| FI (1) | FI954447A (el) |
| GB (1) | GB9306106D0 (el) |
| GR (1) | GR3031293T3 (el) |
| HU (1) | HUT73424A (el) |
| IL (1) | IL109053A (el) |
| NO (1) | NO953647L (el) |
| NZ (1) | NZ262756A (el) |
| PE (1) | PE7595A1 (el) |
| PL (1) | PL175127B1 (el) |
| RO (1) | RO114738B1 (el) |
| WO (1) | WO1994021267A1 (el) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2130069B1 (es) * | 1997-04-10 | 2000-03-01 | Basf Labiana S A | Preparacion farmaceutica con liberacion retardada del producto activo. |
| US6946137B2 (en) * | 2001-10-19 | 2005-09-20 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
| MXPA05004219A (es) * | 2002-10-25 | 2005-06-08 | Akzo Nobel Nv | Composicion farmaceutica de liberacion prolongada. |
| JP2023553202A (ja) | 2020-12-08 | 2023-12-20 | ルミナント バイオテク コーポレーション リミテッド | 動物に物質を送達するための装置および方法の改善 |
| CN116407505A (zh) * | 2023-03-28 | 2023-07-11 | 青岛康地恩动物药业有限公司 | 一种高生物利用度泰万菌素干混悬剂及制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2105589B (en) * | 1981-09-11 | 1985-10-23 | Wellcome Found | Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent |
| PT76448B (en) * | 1982-04-05 | 1986-03-20 | Merck Sharp & Dohme | Process for preparing stabilization of unstable drugs or food supplements containing antibiotics mainly ephrotomycin |
| US4597969A (en) * | 1982-04-05 | 1986-07-01 | Merck Sharp & Dohme | Stabilization of unstable drugs or food supplements |
| US4994227A (en) * | 1986-03-10 | 1991-02-19 | American Cyanamid Company | Method for the preparation of sustained released bolus formulation |
| ATE66600T1 (de) * | 1986-03-10 | 1991-09-15 | American Cyanamid Co | Verfahren zur herstellung einer bolusformulierung mit verzoegerter freisetzung. |
-
1993
- 1993-03-24 GB GB939306106A patent/GB9306106D0/en active Pending
-
1994
- 1994-03-21 PE PE1994238718A patent/PE7595A1/es not_active Application Discontinuation
- 1994-03-21 IL IL10905394A patent/IL109053A/en not_active IP Right Cessation
- 1994-03-22 DK DK94909996T patent/DK0689444T3/da active
- 1994-03-22 DE DE69419408T patent/DE69419408T2/de not_active Expired - Lifetime
- 1994-03-22 PL PL94310804A patent/PL175127B1/pl unknown
- 1994-03-22 AU AU62621/94A patent/AU669435B2/en not_active Ceased
- 1994-03-22 ES ES94909996T patent/ES2135568T3/es not_active Expired - Lifetime
- 1994-03-22 CA CA002158662A patent/CA2158662C/en not_active Expired - Fee Related
- 1994-03-22 KR KR1019950704128A patent/KR100283369B1/ko not_active IP Right Cessation
- 1994-03-22 CN CN94192118A patent/CN1096268C/zh not_active Expired - Fee Related
- 1994-03-22 RO RO95-01655A patent/RO114738B1/ro unknown
- 1994-03-22 JP JP6520820A patent/JPH08508032A/ja not_active Ceased
- 1994-03-22 WO PCT/GB1994/000578 patent/WO1994021267A1/en active IP Right Grant
- 1994-03-22 EP EP94909996A patent/EP0689444B1/en not_active Expired - Lifetime
- 1994-03-22 HU HU9502700A patent/HUT73424A/hu unknown
- 1994-03-22 BR BR9406202A patent/BR9406202A/pt not_active Application Discontinuation
- 1994-03-22 NZ NZ262756A patent/NZ262756A/en not_active IP Right Cessation
- 1994-03-22 AT AT94909996T patent/ATE181834T1/de not_active IP Right Cessation
-
1995
- 1995-09-15 NO NO953647A patent/NO953647L/no not_active Application Discontinuation
- 1995-09-20 FI FI954447A patent/FI954447A/fi unknown
- 1995-10-23 BG BG100078A patent/BG62352B1/bg not_active Expired - Lifetime
-
1999
- 1999-09-22 GR GR990402391T patent/GR3031293T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL109053A0 (en) | 1994-06-24 |
| HU9502700D0 (en) | 1995-11-28 |
| PL310804A1 (en) | 1996-01-08 |
| CN1096268C (zh) | 2002-12-18 |
| FI954447A (fi) | 1995-11-15 |
| BR9406202A (pt) | 1995-12-12 |
| WO1994021267A1 (en) | 1994-09-29 |
| EP0689444B1 (en) | 1999-07-07 |
| KR960700732A (ko) | 1996-02-24 |
| DE69419408D1 (de) | 1999-08-12 |
| GB9306106D0 (en) | 1993-05-12 |
| KR100283369B1 (ko) | 2001-03-02 |
| NO953647D0 (no) | 1995-09-15 |
| ATE181834T1 (de) | 1999-07-15 |
| PL175127B1 (pl) | 1998-11-30 |
| JPH08508032A (ja) | 1996-08-27 |
| CA2158662C (en) | 2009-06-30 |
| CN1123525A (zh) | 1996-05-29 |
| EP0689444A1 (en) | 1996-01-03 |
| FI954447A0 (fi) | 1995-09-20 |
| NO953647L (no) | 1995-11-22 |
| HUT73424A (en) | 1996-07-29 |
| BG100078A (bg) | 1996-07-31 |
| AU669435B2 (en) | 1996-06-06 |
| BG62352B1 (bg) | 1999-09-30 |
| IL109053A (en) | 1999-09-22 |
| DE69419408T2 (de) | 1999-10-28 |
| PE7595A1 (es) | 1995-04-25 |
| DK0689444T3 (da) | 1999-11-22 |
| AU6262194A (en) | 1994-10-11 |
| NZ262756A (en) | 1997-06-24 |
| RO114738B1 (ro) | 1999-07-30 |
| ES2135568T3 (es) | 1999-11-01 |
| CA2158662A1 (en) | 1994-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2529167T3 (es) | Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares | |
| NZ512287A (en) | Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester | |
| CA2063576A1 (en) | Slow release vehicles for minimizing skin irritancy of topical compositions | |
| AU4275597A (en) | Erythropoietin drug delivery system | |
| GB1450512A (en) | Anhydrous candicidin foam compositions | |
| DE69510755D1 (de) | Ölsäurereiche Polyolester, diese enthaltende Kompositionen und funktionelle Schmierfluide und Fette | |
| GR3025029T3 (en) | Coolant compositions with reduced stinging. | |
| GR3005191T3 (el) | ||
| EP1066827A3 (en) | Foaming oil gel compositions | |
| PT1014941E (pt) | Formulação farmacêutica extrudível por termofusão | |
| CA2317471A1 (en) | Dry emollient compositions | |
| MX9703895A (es) | Composiciones topicas para el cuidado de la piel que contienen esteres de acido carboxilico de poliol espesado como agentes de acondicionamiento de la piel. | |
| WO2000015179A3 (en) | Cosmetic composition | |
| HU9502700D0 (en) | Tylosin containing sustained release veterinary compositions | |
| CA2313878A1 (en) | Composition for suppressing behavior problems of pets | |
| GR3022513T3 (en) | Composition formed of an aqueous dispersion of stabilized vesicles of amphiphilic non-ionic lipids | |
| GB9325395D0 (en) | Compositions | |
| CA2285052A1 (en) | Improvements in or relating to long-acting antimicrobials | |
| JPS5750914A (en) | Betamethasone external pharmaceutical | |
| CA2369697A1 (en) | Process and composition for enhancing the action of vitamin a on the cellular activity of an individual, and use of vitamin c | |
| WO1998033478A3 (en) | Rna- and dna-based active agents in nanoparticles | |
| MX9703896A (es) | Composiciones topicas para el cuidado de la piel que contienen esteres de acido carboxilico de poliol liquido no oclusivo como agentes de acondicionamiento de la piel. | |
| WO2001003774A3 (en) | Pharmaceutical composition for the treatment of calcification | |
| HUP9903088A2 (hu) | Mupirocint és klórhexidint tartalmazó gyógyszerkészítmény | |
| MY109207A (en) | Subcutaneous implants based on nomegestrol derivatives |